Literature DB >> 32788033

SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020.

Mutien Garigliany, Anne-Sophie Van Laere, Cécile Clercx, Didier Giet, Nicolas Escriou, Christèle Huon, Sylvie van der Werf, Marc Eloit, Daniel Desmecht.   

Abstract

In March 2020, a severe respiratory syndrome developed in a cat, 1 week after its owner received positive test results for severe acute respiratory syndrome coronavirus 2. Viral RNA was detected in the cat's nasopharyngeal swab samples and vomitus or feces; immunoglobulin against the virus was found in convalescent-phase serum. Human-to-cat transmission is suspected.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; Felis silvestris catus; SARS-CoV-2; cat; coronavirus disease; pandemic; respiratory infections; reverse zoonosis; severe acute respiratory syndrome coronavirus 2; transmission; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32788033      PMCID: PMC7706966          DOI: 10.3201/eid2612.202223

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


We report the investigation of illness and infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a household cat in Belgium (1). The cat was a female domestic shorthair, »15 years of age, that had been adopted 2 years earlier. The owner considered the cat to have been healthy since adoption, although it had never been assessed by a veterinarian. In February 2020, the owner took part in a 7-day tour to a mountain resort in Lombardy, Italy. The day after returning home, March 2, the owner felt suddenly too short of breath to conduct normal activities. As a precautionary measure, the family doctor decided to take a deep oropharyngeal swab sample and asked the patient to remain at home until the test result was reported. Over the next 10 days, the patient experienced a series of general, respiratory, and then digestive symptoms consistent with the clinical signs associated with coronavirus disease (COVID-19) (Figure). On March 6, the swab sample was declared positive for the SARS-CoV-2 genome, and home quarantine was extended until the end of March.
Figure 7

Timeline of disease course for human and cat with SARS-CoV-2 infection, by days from illness onset according to the cat owner, Belgium, February 22–March 25, 2020. NA, not available; ND, not determined; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Timeline of disease course for human and cat with SARS-CoV-2 infection, by days from illness onset according to the cat owner, Belgium, February 22–March 25, 2020. NA, not available; ND, not determined; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. During that time, the patient’s household cat was asymptomatic (Video 1). However, 1 week later, the cat suddenly demonstrated clinical signs; the cat was found prostrated and vomiting in her litter, then showed pronounced lethargy, poor appetite to anorexia, vomiting, and diarrhea (Figure). Several days later, the clinical signs worsened. The cat demonstrated sneezing (Video 2; Video 3); a harsh, productive cough several times a day; episodes of paroxysmal reverse sneezing (Video 4; Video 5); labored breathing with increased respiratory effort and frequency; and emaciation (Video 6). The clinical impression at this time was that of a restrictive breathing pattern suggestive of substantial involvement of parenchyma, pleura, or both. The cat’s condition then gradually improved; she became less lethargic, vomiting stopped, feces resumed normal consistency, episodes of cough became less frequent, and appetite quickly improved. The cat recovered completely within <2 weeks.
Video 1

Cat showing healthy behavior (March 6, 2020). Video forthcoming

Video 2

Cat showing reverse sneezing, suggestive of the presence of mucous or mucopurulent material in the throat/nasopharyngeal area (March 16, 2020). Video forthcoming

Video 3

Close-up of cat’s face showing open-mouth breathing, suggesting severe dyspnea, Video forthcoming nasal/nasopharyngeal obstruction, or both. The cat appears to be exhausted (March 15, 2020).

Video 4

Cat showing productive cough with terminal retch (March 14, 2020). Video forthcoming

Video 5

Cat showing productive cough with terminal retch (March 16, 2020). Video forthcoming

Video 6

Dry and deep cough with terminal retch and restrictive breathing pattern, suggestive of substantial parenchymal involvement. Cat is emaciated (March 17, 2020). Video forthcoming

Cat showing healthy behavior (March 6, 2020). Video forthcoming Cat showing reverse sneezing, suggestive of the presence of mucous or mucopurulent material in the throat/nasopharyngeal area (March 16, 2020). Video forthcoming Close-up of cat’s face showing open-mouth breathing, suggesting severe dyspnea, Video forthcoming nasal/nasopharyngeal obstruction, or both. The cat appears to be exhausted (March 15, 2020). Cat showing productive cough with terminal retch (March 14, 2020). Video forthcoming Cat showing productive cough with terminal retch (March 16, 2020). Video forthcoming Dry and deep cough with terminal retch and restrictive breathing pattern, suggestive of substantial parenchymal involvement. Cat is emaciated (March 17, 2020). Video forthcoming A series of laboratory analyses were then conducted (Appendix). The cat’s owner collected 26 swab samples according to instructions received by telephone; 16 samples contained varying amounts of the SARS-CoV-2 genome (Table). Overall, positive samples were detected March 11–24. The cat was examined by veterinarians at the time of blood sampling on day 22 after onset of first symptoms. Clinical examination of the cat was unremarkable at that time, and auscultation of the thorax revealed no abnormalities. Results of a complete blood count and a serum biochemistry panel were within reference ranges. Presence of serum IgG was first sought by Western blotting of mock-exposed and SARS-CoV-2–exposed Vero E6 cells lysates. In convalescent-phase serum, 5 protein bands that were simultaneously absent from mock-exposed Vero E6 cell lysates were identified (Appendix Figure). Furthermore, the convalescent-phase serum was positive by double-epitope sandwich ELISA and for 2 of the 3 antigens tested by double-epitope luciferase assay (Table; Appendix Table). Whereas serum samples from 30 control cats and 10 control humans were negative by virus neutralization assay, the convalescent-phase serum samples from the cat and her owner were positive; endpoints were 1:512 for the cat and 1:128 for the human.
Table

Severe acute respiratory syndrome coronavirus 2 genome loads measured by qRT-PCR in a series of consecutive swab samples from cat, Belgium, March 2020*

DateOropharyngeal swab samples
Vomitus
Feces
β-actin geneN geneβ−actin geneN geneβ-actin geneN gene
11NSNS26.9523.5 ± 0.135.533.3 ± 0.2
1233.438.2 ± 0.5NSNS32.934.8 ± 0.0
1337.837.9 ± 0ND34.9 ± 0.134.437,6 ± 0,1
1425.139.3 ± 0.1NSNS30.735.1 ± 0.1
1535.935.7 ± 0.1NSNS27.833.2 ± 0.1
1638.2NegativeNSNS26.035.1 ± 0
1727.138.2 ± 0NSNS28.7Negative
1826.7NegativeNSNS36.137.9 ± 0
19NSNSNSNS27.939.0 ± 0
20NSNSNSNS30.1Negative
21NSNS29.933.8 ± 0.132.8Negative
2237.9NegativeNSNS31.7Negative
23NSNSNSNS33.8Negative
25
NS
NS

34.9
Negative

35.0
Negative
*Numbers reported are defined as the number of cycles required for the real-time PCR assay fluorescent signal curve to intersect with a threshold line that exceeds background level (mean ± SD). It is a relative measure of the concentration of the genomic target in the qRT-PCR reaction (the severe acute respiratory syndrome coronavirus 2 N gene or cat β-actin gene); values >40 are considered negative. All samples with qRT-PCR values <40 were analyzed further by a standard gel RT-PCR targeting the coding sequence of the virus spike protein gene followed by Sanger sequencing of the correctly sized amplicon retrieved (»370 bp). Only samples positive for all 3 tests were defined as positive, which was the case for all samples with a value <40 for the N gene aggregated in this table. NS, no sample available; negative, RT-qPCR and/or gel PCR and/or sequencing test failed; qRT-PCR, quantitative reverse transcription PCR.
The cat at first showed general signs, then gastrointestinal signs, and finally respiratory signs, similar to those observed in humans. Subsequently examined samples from the cat revealed viral RNA persisting for about 10 days. With the exception of a vomitus fluid sample collected on March 13, the amounts of viral RNA were relatively low. For this reason, and despite the simultaneous presence of a compatible clinical syndrome and a suggestive chronology of events, we cannot automatically rule out passive contamination of the cat’s samples by its owner. To confirm the hypothesis of a productive infection of the cat, we conducted a series of serologic analyses by using 4 different testing approaches and targeting distinct viral protein targets. All procedures converged toward the same result: the convalescent-phase serum from the cat contained immunoglobulins against SARS-CoV-2, which were absent from the serum from control cats. These antibodies target several distinct viral proteins, and they caused a total neutralizing effect up to a much higher dilution than those from the owner’s serum. This household cat was therefore productively infected with the SARS-CoV-2 virus excreted by its owner, and the infection caused a nonfatal but nevertheless severe disease, mainly of the respiratory system (Videos 2–6). Public health officials are still learning about SARS-CoV-2, but no current evidence indicates that pets play a role in spreading the virus. Therefore, taking measures against companion animals that may compromise their welfare is not justified.

Appendix

Additional materials and methods for study of natural transmission of severe acute respiratory syndrome coronavirus 2 infection from human to cat, Belgium, March 2020.
  55 in total

1.  No Evidence of SARS-CoV-2 Among Flies or Cockroaches in Households Where COVID-19 Positive Cases Resided.

Authors:  Christopher M Roundy; Sarah A Hamer; Italo B Zecca; Edward B Davila; Lisa D Auckland; Wendy Tang; Haley Gavranovic; Sonja L Swiger; Jeffery K Tomberlin; Rebecca S B Fischer; Alex Pauvolid-Corrêa; Gabriel L Hamer
Journal:  J Med Entomol       Date:  2022-07-13       Impact factor: 2.435

2.  Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2.

Authors:  Panli Zhang; Shengxue Luo; Peng Zou; Chaolan Liang; Cong Wang; Jinfeng Li; Yongyin Li; Gang Wang; Ling Zhang; Tingting Li; Chengyao Li
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-22       Impact factor: 5.849

Review 3.  Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models.

Authors:  Young-Il Kim; Mark Anthony B Casel; Young Ki Choi
Journal:  J Microbiol       Date:  2022-03-02       Impact factor: 2.902

4.  No molecular evidence of SARS-CoV-2 infection in companion animals from Veracruz, Mexico.

Authors:  Sokani Sánchez-Montes; Gerardo G Ballados-González; Janete Gamboa-Prieto; Anabel Cruz-Romero; Dora Romero-Salas; Carlos D Pérez-Brígido; María J Austria-Ruíz; Alfredo Guerrero-Reyes; Miguel A Lammoglia-Villagómez; Ireri P Camacho-Peralta; José Á Morales-Narcia; José L Bravo-Ramos; Manuel Barrientos-Villeda; Leopoldo A Blanco-Velasco; Ingeborg Becker
Journal:  Transbound Emerg Dis       Date:  2021-06-02       Impact factor: 4.521

Review 5.  COVID-19 in Farm Animals: Host Susceptibility and Prevention Strategies.

Authors:  Sachin Subedi; Sulove Koirala; Lilong Chai
Journal:  Animals (Basel)       Date:  2021-02-28       Impact factor: 2.752

6.  Assessing the extent of community spread caused by mink-derived SARS-CoV-2 variants.

Authors:  Liang Wang; Xavier Didelot; Yuhai Bi; George F Gao
Journal:  Innovation (Camb)       Date:  2021-06-07

7.  First Description of SARS-CoV-2 Infection in Two Feral American Mink (Neovison vison) Caught in the Wild.

Authors:  Jordi Aguiló-Gisbert; Miguel Padilla-Blanco; Victor Lizana; Elisa Maiques; Marta Muñoz-Baquero; Eva Chillida-Martínez; Jesús Cardells; Consuelo Rubio-Guerri
Journal:  Animals (Basel)       Date:  2021-05-16       Impact factor: 2.752

Review 8.  SARS-CoV-2-Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis.

Authors:  Katarzyna Grudlewska-Buda; Natalia Wiktorczyk-Kapischke; Ewa Wałecka-Zacharska; Joanna Kwiecińska-Piróg; Katarzyna Buszko; Kamil Leis; Klaudia Juszczuk; Eugenia Gospodarek-Komkowska; Krzysztof Skowron
Journal:  J Clin Med       Date:  2021-05-03       Impact factor: 4.241

9.  SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA.

Authors:  Sarah A Hamer; Alex Pauvolid-Corrêa; Italo B Zecca; Edward Davila; Lisa D Auckland; Christopher M Roundy; Wendy Tang; Mia Kim Torchetti; Mary Lea Killian; Melinda Jenkins-Moore; Katie Mozingo; Yao Akpalu; Ria R Ghai; Jessica R Spengler; Casey Barton Behravesh; Rebecca S B Fischer; Gabriel L Hamer
Journal:  Viruses       Date:  2021-05-19       Impact factor: 5.048

10.  Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home.

Authors:  Claudia Schulz; Claudia Wylezich; Kerstin Wernike; Magdalena Gründl; Alexandra Dangel; Christine Baechlein; Donata Hoffmann; Susanne Röhrs; Sabrina Hepner; Nikolaus Ackermann; Andreas Sing; Isabelle Pink; Beate Länger; Holger A Volk; Paul Becher; Gerd Sutter; Antonie Neubauer-Juric; Maren von Köckritz-Blickwede; Martin Beer; Asisa Volz
Journal:  Emerg Infect Dis       Date:  2021-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.